Effect of Surfactant on Morbidity, Mortality, and Resource Use in Newborn Infants Weighing 500 to 1500 g
- 26 May 1994
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (21), 1476-1480
- https://doi.org/10.1056/nejm199405263302102
Abstract
The administration of surfactant decreased mortality, morbidity, and costs of care for very-low-birth-weight infants in clinical trials. The extent to which these benefits can be achieved in the usual clinical settings is not known.This publication has 12 references indexed in Scilit:
- A Controlled Trial of Synthetic Surfactant in Infants Weighing 1250 G or More with Respiratory Distress SyndromeNew England Journal of Medicine, 1991
- Cost implications of different approaches to the prevention of respiratory distress syndrome.Archives of Disease in Childhood, 1991
- Surfactant Replacement Therapy for Respiratory Distress SyndromePEDIATRICS, 1991
- Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndromeThe Journal of Pediatrics, 1991
- Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trialThe Journal of Pediatrics, 1991
- Surfactant Replacement Therapy in Respiratory Distress SyndromeAmerican Journal of Diseases of Children, 1991
- Factors Affecting Surfactant ResponsivenessAnnals of Medicine, 1991
- What Price Prematurity?Family Planning Perspectives, 1989
- A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress SyndromeNew England Journal of Medicine, 1989
- DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASEThe Lancet, 1987